DLGAP1-AS2 knockdown increases chemosensitivity to vandetanib and synergistically inhibits metastatic activity of papillary thyroid cancer cells: experimental and computational approaches
- DOI
- 10.1186/s12885-026-16511-3
- Published
- 2026-08-07
- Container
- BMC Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-026-16511-3,
title = {DLGAP1-AS2 knockdown increases chemosensitivity to vandetanib and synergistically inhibits metastatic activity of papillary thyroid cancer cells: experimental and computational approaches},
author = {Saeedeh Saderi Oskuie and Seyedeh Zahra Bahojb Mahdavi and Abbas Nikravesh and Behzad Baradaran and Amir Hossein Yari and Omid Pourbagherian and Amir Ali Mokhtarzadeh and Fatemeh Oroojalian},
year = {2026},
journal = {BMC Cancer},
doi = {10.1186/s12885-026-16511-3},
url = {https://doi.org/10.1186/s12885-026-16511-3}
}RIS
TY - JOUR TI - DLGAP1-AS2 knockdown increases chemosensitivity to vandetanib and synergistically inhibits metastatic activity of papillary thyroid cancer cells: experimental and computational approaches AU - Saeedeh Saderi Oskuie AU - Seyedeh Zahra Bahojb Mahdavi AU - Abbas Nikravesh AU - Behzad Baradaran AU - Amir Hossein Yari AU - Omid Pourbagherian AU - Amir Ali Mokhtarzadeh AU - Fatemeh Oroojalian PY - 2026 JO - BMC Cancer DO - 10.1186/s12885-026-16511-3 UR - https://doi.org/10.1186/s12885-026-16511-3 ER -
APA
Oskuie, S. S., Mahdavi, S. Z. B., Nikravesh, A., Baradaran, B., Yari, A. H., Pourbagherian, O., Mokhtarzadeh, A. A., & Oroojalian, F. (2026). DLGAP1-AS2 knockdown increases chemosensitivity to vandetanib and synergistically inhibits metastatic activity of papillary thyroid cancer cells: experimental and computational approaches. BMC Cancer. https://doi.org/10.1186/s12885-026-16511-3
Source records
- crossref · retrieved 2026-11-08T04:52:57.057Z